Happy Holidays from all of us at ICON. We’re sending every best wish for health, happiness and success in 2026.
Download Global and China biotech survey reports
Two new survey reports of 260+ Global and China-based biotech leaders are ready to download
Get your copy nowFrom bottlenecks to breakthroughs
Human-centred strategies for faster study starts
Read the whitepaperOptimising vaccine follow-up through early planning
A proactive approach to RWD and tokenisation integration
Read the whitepaperDeveloping AI in software as a medical device (SaMD)
Model and data selection best practices
Read the whitepaper
Featured solutions
Blended solutions
Bespoke, seamless solutions to meet unique sponsor challenges.
Outcome Measures
A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients.
Biotech
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
Cardiac Safety Solutions
End-to-end cardiac safety solutions, including ECG, event monitoring, BPM, long-term Holter monitoring, ECHO and MUGA studies.
Early Clinical and Bioanalytical Solutions
Innovative early clinical solutions that will advance your drug development strategy.
Site & Patient Solutions
Transforming recruitment through patient-centric trials and real-world, real-time data.
Market Access
Expertise in mission-critical pricing, market access, and reimbursement.
Specialty Laboratory Solutions
Supporting precision medicine programs across all phases of drug diagnostic co-development.
Webinars
Strategic approaches for early clinical trials in neurodegenerative diseases
Watch the webinar.
Beyond the bench: The advantages of GMP over USP compounding in early phase development
Watch the webinar.
Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases
Watch the webinar.